Tech, Banks Continue to Slide — Thursday’s IP Market Recap

Markets fell broadly for a second straight day on the heels of unimpressive earnings reports, and a selloff in tech and bank stocks More 

Should I Buy Rite Aid? 3 Pros, 3 Cons

Rite Aid's turnaround continues to gain traction, but does that make it a solid investment? Decide by looking at RAD's pros and cons. More 

Tech Can’t Stop the Rally — Thursday’s IP Market Recap

Technology stocks reversed course as a report showed dramatic slippage in PC shipments, but the Dow and S&P still marched on to new records. More 

3 Generic Drug Stocks to Buy Right Away

Generic drugs are forecast to be the single fastest-growing industry for the next several years. Here are three stocks to profit from this trend. More 

Day Five, Still Alive! — Monday’s IP Market Recap

The Dow Jones set a new high for a fifth-straight day and the S&P 500 edged closer to its all-time peak as investors absorbed good news on the corporate front. More 

Bull’s Eye Report: CVS Caremark (CVS)

CVS Caremark (CVS) has maintained a positive technical set-up through this past week's volatile period, and looks great for a buy at current levels. More 

5 Stocks to Clean Out of Your Attic — Now

Hint: The stocks you should sell today are the stocks you should have sold yesterday, or long before. Don't wait any longer. More